Fact CheckerSign in

NCT06700317Not yet recruiting

Intraoperative Hyperspectral Imaging for Laparoscopic Surgery

Intraoperative Hyperspectral Imaging for Laparoscopic Surgery (LapHSI): a Multicentre Post-market Clinical Study

Source: ClinicalTrials.gov · Last updated 21 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The study aims to evaluate the use of the HyperSnap Surgical System (HSS1) during laparoscopic surgeries, specifically in bowel resections and cholecystectomies.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
20 Nov 2024
Start date
1 Feb 2025
Primary completion date
1 Jul 2025
Lead sponsor
King's College London
NCT number
NCT06700317

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Feb 2025 to the primary completion date, 1 Jul 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy)
  • Patients with a history of previous abdominal surgery and multiply scarred abdomen
  • Patients with a history of previous abdominal surgery and multiply scarred abdomen
  • Patients undergoing emergency surgery

Other illness

  • Colorectal cancer requiring elective bowel resection via a laparoscopic approach.

Age

  • Patients under 18 years of age
  • Patients under 18 years of age

Other

  • Common bile duct diameter ≥ 8mm as assessed using ultrasound
  • Patients unable to provide written informed consent
  • Patients who are pregnant
  • Patients unable to provide written informed consent
  • Patients who are pregnant

Who the study is looking for

  • Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy)
  • Adult patients aged 18 years and over
  • Common bile duct diameter \< 8mm as assessed using ultrasound
  • Patients able to provide written informed consent
  • Colorectal cancer requiring elective bowel resection via a laparoscopic approach.
  • Adult patients aged 18 years and over
  • Patients who are scheduled for elective laparoscopic colon cancer resection
  • Patients able to provide written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.